RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
59 hedge funds and large institutions have $214M invested in Ra Pharmaceuticals, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
1 | +$53.1M | |
2 | +$30.9M | |
3 | +$23.9M | |
4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$20.5M |
5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$12.5M |
Top Sellers
No sellers this quarter